These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 9486676

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.
    Umino K, Fujiwara SI, Ito S, Mashima K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kanda Y.
    Leuk Lymphoma; 2017 Feb; 58(2):316-323. PubMed ID: 27267694
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma.
    Gause A, Roschansky V, Tschiersch A, Smith K, Hasenclever D, Schmits R, Diehl V, Pfreundschuh M.
    Ann Oncol; 1991 Feb; 2 Suppl 2():43-7. PubMed ID: 2049320
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
    Prinz B, Behrens W, Hölzle E, Plewig G.
    Arch Dermatol Res; 1995 Feb; 287(7):621-6. PubMed ID: 8534123
    [Abstract] [Full Text] [Related]

  • 57. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K, Yawalkar N, Jones D, Kupper TS.
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [Abstract] [Full Text] [Related]

  • 58. Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer.
    De Vita F, Turitto G, di Grazia M, Frattolillo A, Catalano G.
    Tumori; 1998 Jul; 84(1):33-8. PubMed ID: 9619711
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Measurement and cellular sources of the soluble interleukin-2 receptor in primary central nervous system lymphoma.
    Kitai R, Sasaki H, Matsuda K, Tsunetoshi K, Yamauchi T, Neishi H, Matsumura K, Tsunoda A, Takeuchi H, Sato K, Kikuta K.
    Brain Tumor Pathol; 2013 Jan; 30(1):34-9. PubMed ID: 22399193
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.